CORC  > 武汉大学
Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways
Liu Li; Lu Huizhi; Wang Binu; Deng Xinxin; Wu Longjun; Yang Liping; Zhang Yingying
刊名MEDICAL SCIENCE MONITOR
2018
卷号24
关键词Apoptosis Cell Cycle Checkpoints Cell Migration Assays
ISSN号1643-3750
DOI10.12659/MSM.910702
URL标识查看原文
收录类别SCIE
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4225296
专题武汉大学
推荐引用方式
GB/T 7714
Liu Li,Lu Huizhi,Wang Binu,et al. Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways[J]. MEDICAL SCIENCE MONITOR,2018,24.
APA Liu Li.,Lu Huizhi.,Wang Binu.,Deng Xinxin.,Wu Longjun.,...&Zhang Yingying.(2018).Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways.MEDICAL SCIENCE MONITOR,24.
MLA Liu Li,et al."Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways".MEDICAL SCIENCE MONITOR 24(2018).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace